Tony Cooper is a seasoned leader in biomedical research and therapeutics, currently serving as the Head of Strategic Planning for Immunology and Inflammation at Sanofi. They co-founded and hold the position of CEO at Aclys Bio, driving innovation in precision oncology therapeutics. Tony's extensive background includes roles as Director of Immunology at Excelimmune Inc., Staff Scientist at VGTI Florida, and Research Scientist at Adimab, LLC. They also completed a Ph.D. in Immunology at the University of Chicago and contributed as a Postdoctoral Fellow at The Scripps Research Institute. Prior experience includes quality control at Hydrite Chemical Co. and founding roles in Javelin Oncology, focusing on precision immune medicine for cancer treatment.
This person is not in the org chart
This person is not in any teams
This person is not in any offices